Open AccessGenetic variants in anti-Müllerian hormone-related genes and breast cancer risk: results from the AMBER consortium
Author(s) -
Hazel B. Nichols,
Mariaelisa Graff,
Jeannette T. Bensen,
Kathryn L. Lunetta,
Katie M. O’Brien,
Melissa A. Troester,
Lindsay A. Williams,
Kristin L. Young,
Chi Chen Hong,
Song Yao,
Christopher A. Haiman,
Edward A. Ruiz-Narváez,
Christine B. Ambrosone,
Julie R. Palmer,
Andrew F. Olshan
Publication year - 2020
Publication title -
breast cancer research and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.908
H-Index - 154
eISSN - 1573-7217
pISSN - 0167-6806
DOI - 10.1007/s10549-020-05944-4
Subject(s) - breast cancer , medicine , anti müllerian hormone , oncology , odds ratio , single nucleotide polymorphism , menopause , cancer , gynecology , breast disease , logistic regression , confidence interval , genotype , hormone , biology , gene , genetics
Circulating anti-Müllerian hormone (AMH) levels are positively associated with time to menopause and breast cancer risk. We examined breast cancer associations with single nucleotide polymorphisms (SNPs) in the AMH gene or its receptor genes, ACVR1 and AMHR2, among African American women.